24 June 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics investigates the cardiovascular safety profile of 5-HT4 agonists developed for GI disorders.
The nonselective 5-HT4 receptor agonists, cisapride and tegaserod have been associated with cardi
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors